Centiva Capital’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-9,899
Closed -$238K 1677
2024
Q3
$238K Sell
9,899
-6,267
-39% -$143K ﹤0.01% 1722
2024
Q2
$322K Buy
+16,166
New +$315K 0.01% 1419
2022
Q1
Sell
-7,723
Closed -$268K 1611
2021
Q4
$268K Buy
7,723
+1,050
+16% +$33.9K 0.01% 934
2021
Q3
$207K Buy
+6,673
New +$226K 0.01% 912

Other funds holding AVNS

Centiva Capital's AVNS Position: Q4 2024 in Review

Centiva Capital sold out of Avanos Medical (AVNS) in Q4 2024, closing a stake of 9,899 shares — an estimated $238K sold.

Centiva Capital first reported a position in AVNS in Q3 2021 and held it in 4 quarters. The position peaked at $322K in Q2 2024. 258 funds tracked by Wall St. Rank hold AVNS as of Q4 2024.

  • Centiva Capital reported no remaining Avanos Medical position as of Q4 2024 after selling out during the quarter.
  • Centiva Capital sold 9,899 Avanos Medical shares in Q4 2024, an estimated $238K.
  • Centiva Capital first reported a position in Avanos Medical in Q3 2021 and held it in 4 quarters.
  • Centiva Capital's Avanos Medical position peaked at $322K in Q2 2024.
  • 258 funds tracked by Wall St. Rank held Avanos Medical as of Q4 2024.

Based on Centiva Capital's 13F filing for Q4 2024, filed 14 Feb 2025.